TiHo Hannover

Name

TiHo Hannover

Legal name

Stiftung Tierärztliche Hochschule Hannover

Website

https://tiho-hannover.de

Company type

Private

Founded year

1778

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Veterinary Higher Education and Clinical Services

NAICS

Veterinary Services (54194), Veterinary Services (541940), Medical and Diagnostic Laboratories (62151), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Veterinary Medicine Universities (EDAHAGAG)

akta.pro secondary industries

Veterinary Specialty Referral Hospitals (Multi-specialty) (HLAMACAB), Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA), Veterinary Public Health Laboratories (Reference & Confirmatory) (HLAMAJAH)

Keywords

• Veterinary medicine education
• Veterinary clinical services
• Animal health research
• Infectious disease research
• Veterinary public health

Headquarters

HQ city

Hanover

HQ country

Germany

HQ region

Europe

Offices8 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Public Higher Education Funding: As a public foundation under German public law (Stiftung öffentlichen Rechts), TiHo Hannover receives government funding from the State of Lower Saxony (Land Niedersachsen) and federal sources for its educational, research, and clinical missions.
2. Tuition and Student Fees: Modular tuition fees for degree programmes including veterinary medicine, biology (M.Sc. Animal Biology and Biomedical Sciences), and food technology (M.Sc. Food Process and Product Engineering), as well as continuing education programmes (Fachtierarztausbildung, Diplomate, BEST-VET, M.Sc. Veterinary Public Health).
3. Veterinary Clinical Services: Revenue from providing veterinary clinical services across its animal clinics: Clinic for Poultry, Clinic for Small Animals, Clinic for Horses, Clinic for Cattle, Clinic for Swine/Small Ruminants, and Unit for Reproductive Medicine. Services include 24-hour emergency services, herd health services, diagnostic laboratories, and accredited spermatological laboratory.
4. Research Grants and Contracts: Third-party research funding from organizations including the German Research Foundation (DFG), German Center for Infection Research (DZIF), European Commission (EU4Health, HaDEA), COFONI (approximately 19 million euros from the State of Lower Saxony), and various industry partnerships.
5. Diagnostic and Laboratory Services: Fee-for-service diagnostic laboratory testing for veterinarians and animal owners, including clinical-endocrinological laboratory, spermatological laboratory, and diagnostics for livestock and small animals.

Pricing tiers

Distribution channels5 records

Marketing channels5 records

Core offering

TiHo Hannover is Germany's only independent veterinary university, operating as a public foundation under state law that delivers veterinary medicine education (Staatsexamen, M.Sc., PhD, continuing education), operates six species-specialised veterinary clinics with 24/7 emergency care, and conducts biomedical and infectious disease research across 17+ institutes. Revenue derives from state appropriations, tuition, clinical and diagnostic service fees, and third-party research grants.

Product overview

TiHo Hannover (Stiftung Tierärztliche Hochschule Hannover) is a university of veterinary medicine offering a comprehensive portfolio of educational programs and clinical services. The institution provides veterinary medicine degree programs, master's programs in Animal Biology and Food Process Engineering, specialized PhD programs through Graduate School HGNI, and continuing education including Fachtierarztausbildung and BEST-VET programs. TiHoStudIS/TiHoDozIS serve as student and lecturer portals. The university operates multiple veterinary clinics (poultry, small animals, horses, farm animals, exotic pets, reproductive medicine) and research institutes covering anatomy, biochemistry, biometry, immunology, food safety, microbiology, parasitology, pathology, pharmacology, physiology, virology, and more. Virtual research centers include VZET (alternatives to animal testing), Zentrum für Infektionsmedizin (infectious medicine), European Vaccines Hub (pandemic preparedness), COFONI (COVID-19 research), and VZRN (reproductive medicine).

Differentiator

Problem solved

Functional benefit

Brands

• VZET: Virtual center for alternative and complementary methods to animal experimentation (3R concept: Replacement, Reduction, Refinement)
• VZRN
• Zentrum für Infektionsmedizin
• In-vitro-Methodenbörse

Products and services

• Veterinary Medicine Studies (Tiermedizin studieren) Core veterinary medicine degree programme (Staatsexamen) covering animal health, disease diagnosis, and treatment across multiple species; admission is regulated centrally through Hochschulstart and trains students for the licensed veterinary profession.
• M.Sc. Animal Biology and Biomedical Sciences International master's degree programme in biology focused on animal biology and biomedical sciences, recruiting through the International Academic Office.
• M.Sc. Food Process and Product Engineering (MSc FPPE)
• Graduate School HGNI (Hannover Graduate School for Veterinary Research and Animal Biology)
• PhD Programme "Animal and Zoonotic Infections"
• PhD Programme "Systems Neuroscience"
• PhD Programme "Veterinary Research and Animal Biology"
• Fachtierarztausbildung (Specialist Veterinary Training)
• Diplomateausbildung (Diplomate Certification Programme)
• BEST-VET Berufsbegleitende Studienangebote in der Veterinärmedizin
• Veterinary Clinical Services (six species-specialised clinics and Unit for Reproductive Medicine)

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

32 partnerships are on record, tiered core and minor.

• European Vaccines Hub (EVH)coreStrategic or Co-development Partner · 1 January 2025EVH is a European research network preparing Europe for future large-scale infectious disease events (epidemics/pandemics), particularly in vaccine and antibody development. Established 2025 with funding from EU4Health programme via HaDEA. TiHo participates as a DZIF member institution, with Prof. Dr. Asisa Volz (Institute of Virology) serving as co-leader of preclinical studies (Pillar 2). The network comprises 11 funded and 13 associated institutions across 7 European countries.
• COVID-19 Forschungsnetzwerk Niedersachsen (COFONI)coreStrategic or Co-development Partner · 1 October 2020COFONI is Lower Saxony's COVID-19 research network founded in October 2020 to address the pandemic and prepare for future health crises. Funded with approximately 19 million euros by the State of Lower Saxony. Coordinated by Universitätsmedizin Göttingen (UMG). TiHo's Prof. Dr. Maren von Köckritz-Blickwede (Institute of Biochemistry) serves as Deputy Speaker and leads the technology platform. Network comprised 8 research focus areas, 38 cooperation projects, and 25 partner institutions spanning basic, clinical, and social sciences.
• Deutsches Zentrum für Infektionsforschung (DZIF) / German Center for Infection ResearchcoreStrategic or Co-development PartnerDZIF is the German national infection research consortium. TiHo participates as one of nine German DZIF member institutions in the EVH network. Under DZIF leadership, TiHo collaborates with Philipps-Universität Marburg, Helmholtz Munich, HZI Braunschweig, LMU Klinikum München, TU München, Uniklinik Köln, UKE Hamburg-Eppendorf, and Universität Tübingen on vaccine development.
• Sclavo Vaccines Association (Italy)coreStrategic or Co-development PartnerNon-profit organization based in Arezzo, Italy, dedicated to promoting vaccine research and development. Coordinates the European Vaccines Hub (EVH) project. Acts as the lead coordinating organization for the EVH consortium.
• European Commission / GD HERAcoreStrategic or Co-development PartnerHealth Emergency Preparedness and Response Authority (DG HERA) of the European Commission. EVH cooperates with GD HERA on pandemic preparedness. HaDEA co-finances EVH on behalf of the European Commission through the EU4Health programme.
• Sanofi (Industrial Partnership)minorStrategic or Co-development PartnerEVH industrial partnership with Sanofi for development of a mucosal vaccine against avian influenza H5N1.
• BioNTech (Industrial Partnership)minorStrategic or Co-development PartnerAdvanced discussions between EVH and BioNTech for clinical development of an mRNA-based vaccine candidate against Mpox.
• Universitätsmedizin Göttingen (UMG) / University Medicine GöttingencoreStrategic or Co-development PartnerLeading partner and coordinator of COFONI. Georg-August-Universität Göttingen and its medical faculty serve as the main coordinating institution for the Lower Saxony COVID-19 research network.
• Helmholtz-Zentrum für Infektionsforschung (HZI) / Helmholtz Centre for Infection ResearchcoreStrategic or Co-development PartnerGermany's largest infection research center. Founding member of COFONI and partner in the cross-institutional Zentrum für Infektionsbiologie (ZIB) together with TiHo, MHH, and Leibniz University Hannover. HZI in Braunschweig.
• Medizinische Hochschule Hannover (MHH) / Hannover Medical SchoolcoreStrategic or Co-development PartnerMajor partner in COFONI and the Zentrum für Infektionsbiologie (ZIB). MHH hosts Prof. Dr. Christine S. Falk (Institute of Transplantation Immunology) who chairs the COFONI Long-/Post COVID Committee.
• Deutsche Primatenzentrum – Leibniz-Institut für Primatenforschung (DPZ) / German Primate CentercoreStrategic or Co-development PartnerLeibniz Institute and founding member of COFONI, specializing in primate research critical for COVID-19 and infectious disease studies. Director Prof. Dr. Stefan Treue participated in the COFONI closing symposium.
• TWINCORE – Zentrum für Experimentelle und Klinische InfektionsforschungcoreStrategic or Co-development PartnerJoint venture between MHH and HZI, participating in COFONI network as a centre specializing in experimental and clinical infection research.
• Zentrum für Individualisierte Infektionsmedizin (CiiM)coreStrategic or Co-development PartnerPartner in COFONI network focusing on personalized infection medicine approaches.
• Technische Universität Braunschweig (TU Braunschweig)minorStrategic or Co-development PartnerTechnical university participating in COFONI network, contributing technical expertise to the consortium.
• Leibniz Universität HannoverminorStrategic or Co-development PartnerMajor university in Hannover participating in COFONI and part of the Zentrum für Infektionsbiologie (ZIB) alongside TiHo, MHH, and HZI.
• Charta der Vielfalt (Diversity Charter)minorOthersTiHo is a signatory to the Charta der Vielfalt, a self-commitment declaration with over 3,900 organizations in Germany promoting diversity and appreciation in the workplace, covering age, ethnicity, gender identity, disability, religion, sexual orientation, and social origin.
• ÖKOPROFIT Project (City of Hannover)minorOthersCooperation project of the City and Region of Hannover (Wirtschaftsförderung Hannover) promoting ecological project for integrated environmental technology. TiHo has been a participant since 2013 and holds ÖKOPROFIT Betrieb status. Programme focuses on environmental protection, energy/waste management, and internal process optimization.
• International Academic Office – Partner UniversitiesminorStrategic or Co-development PartnerTiHo maintains international academic partnerships and student exchange agreements through its International Academic Office (Wege an die TiHo / Wege ins Ausland). The office facilitates international student mobility and manages cooperation agreements with partner universities worldwide.
• Friedrich-Loeffler-Institut (FLI) / Institute for Animal Genetics, MarienseecoreStrategic or Co-development PartnerFederal research institute for animal health and genetics, a key partner in the Virtuelles Zentrum für Reproduktionsmedizin Niedersachsen (VZRN). Prof. Dr. Claudia Klein (FLI) serves as Chair of the VZRN board. Collaboration focuses on livestock genetics and reproductive biotechnology.
• Institut Pasteur (France)coreStrategic or Co-development PartnerLeads Pillar 2 (Preclinical Studies) of the European Vaccines Hub. Major French biomedical research institution and one of the founding partners of the EVH consortium.
• Vaccinopolis, University of Antwerp (Belgium)coreStrategic or Co-development PartnerLeads Pillar 3 (Clinical Studies) of the European Vaccines Hub. Specialised vaccine research centre at the University of Antwerp.
• ZEPAI / Paul-Ehrlich-Institut (PEI) (Germany)coreStrategic or Co-development PartnerCenter for Pandemic Vaccines and Therapeutics (ZEPAI) at the Paul-Ehrlich-Institut (PEI), Germany's federal institute for vaccines and biomedical drugs. Leads Pillar 4 (Regulatory Affairs and Manufacturing) of the EVH alongside DZIF.
• Fondazione Biotecnopolo di Siena (Italy)coreStrategic or Co-development PartnerLeads Pillar 1 (Discovery) of the European Vaccines Hub. Italian foundation supporting biotech development in Siena, Italy.
• Academisch Ziekenhuis Leiden (Netherlands)minorStrategic or Co-development PartnerLeiden University Medical Center, affiliated partner in the European Vaccines Hub consortium.
• Norwegian Institute of Public Health (NIPH) (Norway)minorStrategic or Co-development PartnerNorsk Folkeinstitutt, affiliated partner in the European Vaccines Hub consortium.
• Instituto de Biologia Experimental e Tecnológica (iBET) (Portugal)minorStrategic or Co-development PartnerPortuguese research institute in biologia experimental e tecnológica, affiliated partner in the EVH consortium.
• Université libre de Bruxelles (Belgium)minorStrategic or Co-development PartnerULB Brussels, affiliated partner in the European Vaccines Hub consortium.
• Soziologisches Forschungsinstitut Göttingen (SOFI) / Sociological Research Institute GöttingencoreStrategic or Co-development PartnerAffiliated with Georg-August-Universität Göttingen, SOFI focuses on social science research within COFONI, particularly on societal and labour market impacts of the pandemic (Post COVID, working conditions). Prof. Dr. Berthold Vogel serves as co-chair of the COFONI Long-/Post COVID Committee.
• Carl von Ossietzky Universität OldenburgminorStrategic or Co-development PartnerUniversity in Lower Saxony participating in COFONI for social science and society research on pandemic impacts.
• Universität OsnabrückminorStrategic or Co-development PartnerUniversity in Lower Saxony participating in COFONI for social science research on pandemic effects.
• Universität HildesheimminorStrategic or Co-development PartnerUniversity in Lower Saxony participating in COFONI for social science research.
• Leuphana Universität LüneburgminorStrategic or Co-development PartnerUniversity in Lower Saxony participating in COFONI for social science and educational research.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Royal Veterinary College (RVC), University of London: The UK's oldest and largest independent veterinary school and a constituent college of the University of London. Closest international parallel to TiHo's standalone-veterinary-university model with multi-species referral hospitals and a large biomedical research portfolio.
• University of Zurich (Vetsuisse Faculty): Swiss veterinary university faculty jointly operated with the University of Bern. Comparable integrated education-clinic-research model, strong One Health and infectious disease research, and a leading European alternative-methods (3R) program — direct international peer.
• University of Edinburgh – Royal (Dick) School of Veterinary Studies: One of the world's oldest veterinary schools, integrated with the University of Edinburgh's medical school. Comparable multi-species clinical teaching hospital and strong research profile in infectious disease and One Health, with similar international student recruitment model.
• Justus-Liebig-Universität Gießen (Faculty of Veterinary Medicine): One of the five German veterinary training sites. Competes with TiHo for state-level veterinary funding and students; particularly relevant on small animal and livestock clinical services where the two institutions overlap.
• Ludwig-Maximilians-Universität München (Faculty of Veterinary Medicine): Veterinary faculty at one of Germany's largest research universities. Direct competitor in veterinary education, clinical specialty services, and infectious disease research; also a DZIF member institution collaborating with TiHo within EVH.
• Cornell University College of Veterinary Medicine: US-leading veterinary college with comparative medicine, multi-species teaching hospitals (Cornell University Hospital for Animals), and major infectious disease and One Health research output. Comparable breadth across education, research, and clinical specialty services.
• Freie Universität Berlin (Faculty of Veterinary Medicine): One of Germany's five veterinary training sites and TiHo's closest domestic peer. Competes for the same Hochschulstart-allocated veterinary student pool and similar DFG/BMBF research funding, though embedded within a larger general university rather than operating as an independent foundation.

Broad incumbents

• Zoetis: Global animal health pharmaceutical and diagnostics leader. Comparable footprint in veterinary reference diagnostics, livestock reproductive biotechnology, and continuing veterinary education, but at commercial scale and with industry R&D rather than academic/governmental funding.
• Helmholtz-Zentrum für Infektionsforschung (HZI): Germany's largest dedicated infection research center, a founding member of ZIB and COFONI alongside TiHo. Direct overlap on infectious disease research, but with a much larger scale, broader pathogen remit, and stronger translational/industry pipeline.

Regional players

• Friedrich-Loeffler-Institut (FLI): Germany's federal research institute for animal health and livestock genetics. Core VZRN partner with TiHo (Prof. Claudia Klein chairs VZRN). Overlapping remit on livestock infectious disease, EU reference laboratory functions, and reproductive biotechnology — but focused on research rather than education or clinical services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/user/TiHoVideos
• Facebookfacebook.com/tihohannover
• LinkedInlinkedin.com/company/stiftung-tierrztliche-hochschule-hannover
• Instagraminstagram.com/tiho_hannover

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TiHo Hannover